<DOC>
	<DOCNO>NCT00900484</DOCNO>
	<brief_summary>RATIONALE : Collecting store sample tissue patient cancer study laboratory may help doctor learn change may occur DNA identify biomarkers related cancer . It may also help doctor learn patient respond treatment . PURPOSE : This laboratory study collect , analyze , store tissue sample patient non-Hodgkin 's lymphoma .</brief_summary>
	<brief_title>SWOG-8819 Collecting , Analyzing , Storing Tissue Samples From Patients With Non-Hodgkin 's Lymphoma</brief_title>
	<detailed_description>OBJECTIVES : - Establish central lymphoma tissue repository fresh snap-frozen tissue patient previously untreated non-Hodgkin 's lymphoma ( NHL ) . - Determine standard set procedure routine acquisition , banking , study tissue sample . - Correlate presently activate phenotyping study future project molecular study DNA RNA status tissue sample clinical result . - Correlate pretreatment phenotype genotype tissue sample patient intermediate- high-grade NHL patient outcome , term complete response rate , time progression , survival . - Correlate lymphoma lineage ( T-cell v B-cell ) , loss class II human histocompatibility antigen status ( HLA-DR-positive v HLA-DR-negative ) , proliferative index ( measure Ki-67 ) , B- T-cell antigen aberrancy ( e.g. , lack Pan B T antigen expression ) outcome patient intermediate- high-grade NHL . OUTLINE : Patients treat SWOG study enrol . Tissue sample obtain treatment begin banked tissue repository . Samples patient intermediate- high-grade non-Hodgkin 's lymphoma analyze three-stage immunohistochemistry use monoclonal antibody B-cell antigen , T-cell antigens , immunoglobulin , CALLA , HLA-DR , anti-interleukin-2 receptor , Ki-67 ( proliferative index ) . Phenotype ( immune marker status , proliferation status , activation status ) correlate response treatment , relapse , overall survival . PROJECTED ACCRUAL : Approximately 495 patient accrue study .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Registered active Southwest Oncology Group ( SWOG ) coordinate treatment protocol previously untreated nonHodgkin 's lymphoma Adequate pretreatment diagnostic tissue available meeting follow requirement : Fresh snapfrozen pretreatment diagnostic biopsy site ( initial biopsy rebiopsy ) 1 Hematoxylin Eosin stain slide 1 paraffin block surgery pathology report PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>stage I adult diffuse large cell lymphoma</keyword>
	<keyword>stage I adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage I adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage II adult diffuse large cell lymphoma</keyword>
	<keyword>stage II adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage II adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage III adult diffuse large cell lymphoma</keyword>
	<keyword>stage III adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage III adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage IV adult diffuse large cell lymphoma</keyword>
	<keyword>stage IV adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage IV adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage I grade 3 follicular lymphoma</keyword>
	<keyword>stage II grade 3 follicular lymphoma</keyword>
	<keyword>stage III grade 3 follicular lymphoma</keyword>
	<keyword>stage IV grade 3 follicular lymphoma</keyword>
	<keyword>stage I adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage II adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage III adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage IV adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage I adult lymphoblastic lymphoma</keyword>
	<keyword>stage II adult lymphoblastic lymphoma</keyword>
	<keyword>stage III adult lymphoblastic lymphoma</keyword>
	<keyword>stage IV adult lymphoblastic lymphoma</keyword>
	<keyword>stage I adult Burkitt lymphoma</keyword>
	<keyword>stage II adult Burkitt lymphoma</keyword>
	<keyword>stage III adult Burkitt lymphoma</keyword>
	<keyword>stage IV adult Burkitt lymphoma</keyword>
</DOC>